BlackRock Institutional Trust’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$104M Buy
4,726,960
+113,117
+2% +$2.32M 0.02% 902
2016
Q3
$73.8M Buy
4,613,843
+31,548
+0.7% +$360K 0.01% 1048
2016
Q2
$37.8M Buy
4,582,295
+306,075
+7% +$2.73M 0.01% 1411
2016
Q1
$29.9M Sell
4,276,220
-2,101,921
-33% -$10.6M ﹤0.01% 1546
2015
Q4
$34.2M Sell
6,378,141
-896,590
-12% -$5.73M 0.01% 1496
2015
Q3
$47.1M Buy
+7,274,731
New +$76.1M 0.01% 1251

Other funds holding CC

BlackRock Institutional Trust's CC Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Chemours (CC) stake by 2.5% in Q4 2016, buying an estimated $2.32M and bringing the position to 4,726,960 shares worth $104M. The position accounts for 0.02% of the portfolio, ranked #902.

BlackRock Institutional Trust first reported a position in CC in Q3 2015 and has held it in 6 quarters since. 417 funds tracked by Wall St. Rank hold CC as of Q4 2016.

  • BlackRock Institutional Trust held 4,726,960 shares of Chemours worth $104M as of Q4 2016.
  • BlackRock Institutional Trust bought 113,117 Chemours shares in Q4 2016, an estimated $2.32M.
  • Chemours made up 0.02% of BlackRock Institutional Trust's portfolio in Q4 2016, its #902 holding.
  • BlackRock Institutional Trust first reported a position in Chemours in Q3 2015 and has held it in 6 quarters since.
  • 417 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.